NTLA
Intellia Therapeutics Inc.
$9.02
-$0.53(-5.55%)
40
Overall
60
Value
25
Tech
36
Quality
Market Cap
$1.08B
Volume
3.41M
52W Range
$5.90 - $28.25
Target Price
$22.08
EPS Estimates Overview
| Current Quarter | $-0.99 | Next Quarter | $-0.94 |
| Current Year | $-3.97 | Next Year | $-3.6 |
| QoQ Growth | +5.1% | YoY Growth | +9.3% |
| 3Y EPS CAGR | +0.0% | Target Price | $22.08 |
| Consensus | Buy | Upside | +144.8% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | NTLA | $9.02 | -5.5% | 3.41M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Intellia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW